
GI Insights
ReachMD
Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
Location:
United States
Networks:
ReachMD
Description:
Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
Language:
English
Website:
http://www.reachmd.com/
Episodes
Improving Postsurgical Outcomes in Crohn’s Disease
2/6/2025
Guest: Elisa K. Boden, MD
For patients with Crohn’s disease who require surgery, a variety of risk factors are involved in postoperative recovery and disease control. Learn how prehabilitation programs and lifestyle modifications can reduce complications during and after surgery with Dr. Elisa Boden, an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Oregon Health and Science University.
Duration:00:05:28
Advances in IBD Care: Monitoring with Wearable Sensors
2/6/2025
Guest: Shalini Prasad, PhD
Guest: Sriram Muthukumar, PhD
Host: Charles Turck, PharmD, BCPS, BCCCP
With the constant ups and downs of inflammatory bowel disease (IBD), consistent monitoring can help provide patient-centric care. Dr. Shalini Prasad and Dr. Sriram Muthukumar, co-founders of EnLiSense, join GI Insights to discuss the wearable device they developed to track inflammation markers in IBD patients. Dr. Prasad is the Head of the Department of Bioengineering at the University of Texas at Dallas, and Dr. Muthukumar is the CEO of EnLiSense.
Duration:00:10:29
IBD and Pregnancy: Key Considerations for Patient Management
2/6/2025
Guest: Sara Horst, MD, MPH, FACG
While inflammatory bowel disease (IBD) does not typically cause significant problems in pregnancy, it’s still essential to discuss potential impacts with patients and monitor them closely. Dr. Sara Horst, a Professor of Medicine at Vanderbilt University Medical Center, joins GI Insights to discuss important considerations for pregnant patients with IBD.
Duration:00:05:00
Understanding Surgery in Crohn’s Disease: Risk Factors and Complications
2/6/2025
Guest: Elisa K. Boden, MD
For many patients with Crohn’s disease, surgery is necessary due to complications like strictures and fistulas. Dr. Elisa Boden explores risk factors and potential complications, which she spoke about at the 2025 Crohn’s and Colitis Congress. Dr. Boden is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Oregon Health and Science University.
Duration:00:02:45
New Guidelines for H. pylori Treatment: 2024 Updates from ACG
1/16/2025
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: William Chey, MD
Recent changes to the American College of Gastroenterology’s guidelines on H. pylori treatment provide recommendations for antibiotic susceptibility and optimal patient management. Dr. Peter Buch sits down with the lead author of these guidelines, Dr. William Chey, to learn more about implications for clinical practice. Dr. Chey is the Chief of the Division of Gastroenterology and Hepatology, the H. Marvin Pollard Professor of Gastroenterology, and a Professor of Nutrition Sciences at the University of Michigan.
Duration:00:12:40
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
1/16/2025
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Vivek Kaul, MD
The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guideline co-author Dr. Vivek Kaul. Dr. Kaul is also the Segal-Watson Professor of Medicine at the University of Rochester Medical Center in New York.
Duration:00:12:12
Inflammatory Bowel Disease Management: Choosing the Right Therapy
1/14/2025
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
With so many therapeutic options for Crohn’s disease and ulcerative colitis, it can be challenging to determine which one best matches your patient’s needs and preferences. Onset of action, risk of infections, disease location, and therapeutic goals are all key factors in the decision-making process. To learn more about these considerations, Dr. Peter Buch sits down with Dr. David Hudesman and explores the current therapeutic landscape for inflammatory bowel disease.
Duration:00:08:28
Extraintestinal Manifestations of IBD: Evaluation and Management Strategies
1/14/2025
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
Patients with inflammatory bowel disease (IBD) can experience a variety of extraintestinal manifestations (EIMs), including joint and eye pain and skin rashes. Dr. Peter Buch sits down with Dr. David Hudesman to discuss the impacts of these EIMs and explore best practices for patient management. Dr. Hudesman is a Professor of Medicine at NYU Grossman School of Medicine and Co-Director of NYU Langone’s Inflammatory Bowel Disease Center.
Duration:00:12:57
Crohn’s Disease Care: Diving into the GEM Integrative Risk Score
12/20/2024
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sun-Ho Lee, MD, PhD
Recent research explored the development, validation, and implications of the GEM integrative risk score (GEM-IRS). To learn how this innovative model helps predict the future risk of Crohn’s Disease in healthy first-degree relatives, Dr. Charles Turck speaks with Dr. Sun-Ho Lee, Assistant Professor and clinician scientist at the Inflammatory Bowel Disease Centre at Mount Sinai Hospital in Toronto, Canada.
Duration:00:12:30
Mixed vs. Pure Soybean Oil Lipid Emulsions: How to Select and Monitor Patients
11/20/2024
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Phil Ayers, PharmD, BCNSP, FMSHP, FASHP
Though 100% soybean oil was once the standard for lipid emulsions in parenteral nutrition, mixed lipid emulsions have become more popular over the last decade. But there are a variety of patient-specific factors to consider before determining which type of lipid emulsion is appropriate. Dr. Charles Turck sits down with Dr. Phil Ayers to compare the available options and recommend strategies for selecting and monitoring patients. Dr. Ayers is a Clinical Associate Professor at the University of Mississippi School of Pharmacy and the Chief of Clinical Pharmacy Services in the Department of Pharmacy at Baptist Medical Center in Jackson.
Duration:00:09:59
MCB-PN in Practice: Key Considerations for Patient Selection and Delivery
11/20/2024
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Phil Ayers, PharmD, BCNSP, FMSHP, FASHP
When considering multi-chamber bag parenteral nutrition (MCB-PN), there are a variety of factors to consider, including the patients’ hemodynamic stability and nutrient needs. After a patient is selected, their whole care team must be aware of common risks and challenges to ensure safe and effective delivery. Dr. Charles Turck is joined by Dr. Phil Ayers to discuss appropriate patient selection based on recent updates to ASPEN guidelines and safety considerations. Dr. Ayers is a Clinical Associate Professor at the University of Mississippi School of Pharmacy and the Chief of Clinical Pharmacy Services in the Department of Pharmacy at Baptist Medical Center in Jackson, MI.
Duration:00:13:29
The Role of Neuromodulators in Treating IBS
11/12/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Douglas Drossman, MD
While neuromodulators are primarily used to treat psychiatric disorders, they can also help normalize symptoms of irritable bowel syndrome by targeting the gut-brain axis. In fact, about half of all patients with IBS have the potential to benefit from neuromodulators. Dr. Douglass Drossman joins Dr. Peter Buch to discuss his research on how various neuromodulators can provide relief for IBS patients. Dr. Drossman is the President of the Drossman Center of Education and Practice of Psychosocial Care and Drossman Consulting as well as a Professor Emeritus of Medicine and Psychiatry at the University of North Carolina School of Medicine.
Duration:00:12:28
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
10/30/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: William Grady, MD
While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.
Duration:00:10:27
Grappling with Gastroparesis: Key Management Strategies
10/28/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH
The complexities of gastroparesis can make the disease difficult to diagnose and treat. To help us overcome these challenges, Dr. Kyle Staller joins Dr. Peter Buch to share his preferred strategies for managing patients with gastroparesis. Not only is Dr. Staller an Assistant Professor of Medicine at Harvard University, but he’s also the Director of the GI Motility Lab at the Massachusetts General Hospital.
Duration:00:14:26
Decoding Bloating: Clinical Assessment and Therapeutic Approaches
10/28/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH
Join Dr. Peter Buch as he speaks with Dr. Kyle Staller, Director of the Gastrointestinal Motility Laboratory at Mass General and Assistant Professor of Medicine at Harvard Medical School, about uncovering the cause of a patient’s bloating and determining how to manage it.
Duration:00:12:58
SIBO Solutions: A Guide to Recognition, Diagnosis, and Treatment
10/18/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Eamonn Quigley, MD
Small intestinal bacterial overgrowth (SIBO) is often overdiagnosed due to misconceptions about symptoms and inaccurate tests. Join Dr. Peter Buch and Dr. Eamonn Quigley as they explore considerations for knowing when and how to diagnose and treat SIBO. Dr. Quigley is the Chief of Gastroenterology and Hepatology and the Co-Director of the Lynda K. and David M. Underwood Center for Digestive Disorders at Houston Methodist Hospital.
Duration:00:13:30
Recognizing and Addressing Burnout Among GI Providers
10/18/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Brian E. Lacy, MD, PhD
About 50 percent of gastrointestinal providers are experiencing some degree of burnout, which can lead to a variety of personal and professional challenges. Joining Dr. Peter Buch to discuss the signs of burnout and what you can do to mitigate them is Dr. Brian Lacy, lead author of the “Burnout in Gastrointestinal Providers” article published in the American Journal of Gastroenterology in 2024.
Duration:00:13:07
Managing Pouchitis: A Review of the Updated AGA Guidelines
10/18/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Edward L. Barnes, MD, MPH
Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders.
Duration:00:14:21
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
9/30/2024
Host: Jennifer Caudle, DO
Guest: A. Mark Fendrick, MD
Approximately 40 percent of the eligible U.S. population are not up to date with their colorectal cancer (CRC) screenings, which inspired this study that was presented at Digestive Disease Week (DDW) 2024 to help eliminate the colonoscopy backlog with stool-based CRC screening options. To learn the details of this study and how we can incorporate the findings into practice, join Dr. Jennifer Caudle as she speaks with Dr. Mark Fendrick, Professor of Internal Medicine in the School of Medicine and Professor of Health Management and Policy in the School of Public Health at the University of Michigan.
Duration:00:14:29
The Impacts of Analgesics in Patients with Cirrhosis
9/3/2024
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Naga Chalasani, MD, FAASLD
It’s recommended that if patients with cirrhosis are using acetaminophen long-term, it should be a limited dosage. But should we be avoiding nonsteroidals in patients with decompensation cirrhosis? To walk through the impacts of analgesics in patients with cirrhosis, join Dr. Peter Buch as he speaks with Dr. Naga Chalasani, David W. Crabb Professor of Gastroenterology and Hepatology at Indiana University School of Medicine.
Duration:00:11:45